|
PTP4A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.239500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.104100E-03 |
| Normal-vs-Stage2 |
1.190310E-02 |
| Normal-vs-Stage3 |
1.602900E-03 |
| Normal-vs-Stage4 |
2.043200E-03 |
| Stage1-vs-Stage2 |
6.991800E-01 |
| Stage1-vs-Stage3 |
2.958200E-01 |
| Stage1-vs-Stage4 |
2.987600E-01 |
| Stage2-vs-Stage3 |
7.574800E-01 |
| Stage2-vs-Stage4 |
7.199200E-01 |
| Stage3-vs-Stage4 |
9.258000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.960500E-03 |
| Normal-vs-AfricanAmerican |
3.887600E-01 |
| Normal-vs-Asian |
5.207600E-04 |
| Caucasian-vs-AfricanAmerican |
3.586600E-01 |
| Caucasian-vs-Asian |
7.687600E-02 |
| AfricanAmerican-vs-Asian |
7.852100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.833000E-04 |
| Normal-vs-Female |
9.035800E-03 |
| Male-vs-Female |
7.201000E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.862170E-02 |
| Normal-vs-Age(41-60Yrs) |
1.139640E-03 |
| Normal-vs-Age(61-80Yrs) |
1.137920E-03 |
| Normal-vs-Age(81-100Yrs) |
5.293400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.744200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.960300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.818800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.620800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.241600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.222200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.828000E-01 |
| Classical-VS-Follicular |
1.383840E-02 |
| Classical-VS-Other |
3.242200E-01 |
| Classical-VS-Normal |
1.500010E-02 |
| Tall-VS-Follicular |
2.561200E-01 |
| Tall-VS-Other |
3.593800E-01 |
| Tall-VS-Normal |
7.683600E-03 |
| Follicular-VS-Other |
8.600200E-01 |
| Follicular-VS-Normal |
4.789900E-04 |
| Other-VS-Normal |
3.844400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.402900E-04 |
| Normal-vs-N1 |
1.378910E-03 |
| N0-vs-N1 |
9.152400E-01 |
|
|
